Reading a haemoglobin analysis (HPLC or electrophoresis)
- Reading the test
A haemoglobin analysis tells sickle trait from sickle cell disease and finds thalassaemia carriers, if read with the blood count, iron and age.
What it is
Haemoglobin analysis separates the haemoglobins in a red-cell lysate and reports each as a percentage. High-performance liquid chromatography (HPLC) sorts them by the time they take to leave a column; electrophoresis (alkaline and acid gels, or capillary) sorts them by charge. A normal adult has mostly HbA, a small HbA2 fraction (about 2–3.5%) and very little HbF (under about 1%). Variants such as HbS, HbC and HbE, a raised HbA2 (beta-thalassaemia trait) or raised HbF show up as extra or enlarged peaks.
What it measures and the numbers that matter
- Normal adult: HbA about 95–98%, HbA2 about 2–3.5%, HbF under about 1%.
- Sickle trait (AS): HbA more than HbS (HbS usually about 35–40%), normal MCV, no anaemia. Sickle cell anaemia (SS): no HbA, mostly HbS, variable HbF.
- HbSC: HbS and HbC in roughly equal amounts, no HbA. S/beta-zero thalassaemia: no HbA, HbA2 raised, low MCV; S/beta-plus: HbS more than HbA.
- Beta-thalassaemia trait: HbA2 raised above about 3.5% with a low MCV and MCH; HbF may be slightly raised.
- Alpha-thalassaemia trait usually gives a normal analysis; it is a diagnosis of a low MCV with normal iron and normal HbA2, confirmed by DNA. HbH disease shows a fast HbH peak.
- Newborns have mostly HbF; an 'FS' pattern with no HbA needs repeat testing and family or DNA studies.
How to read it, in order
- Check the context: age, ancestry, transfusion in the last three months, hydroxyurea, and the MCV, MCH and ferritin.
- Is HbA present? None (without recent transfusion) means two abnormal beta genes; present means a trait, compound state with beta-plus, or normal.
- Name any variant peak and its size: HbS, HbC, HbE, HbD and others; confirm HbS with a solubility test or a second method.
- Compare variant with HbA: variant less than HbA suggests trait; a lower than usual HbS fraction in trait suggests co-inherited alpha-thalassaemia.
- Read HbA2: raised with low MCV means beta-thalassaemia trait; normal with low MCV and normal iron suggests alpha-thalassaemia.
- Read HbF: raised with normal indices suggests hereditary persistence of HbF; raised with microcytosis suggests delta-beta thalassaemia or another thalassaemia.
- Where methods disagree or results do not fit the count, confirm with a second method or DNA testing before counselling.
Patterns that matter, side by side
| Pattern | HbA | Variant or HbA2 | MCV | Meaning |
|---|---|---|---|---|
| Sickle trait (AS) | More than HbS | HbS about 35–40% | Normal | Carrier; not a disease, but counsel partners |
| Sickle cell anaemia (SS) | Absent | HbS mostly; HbF variable | Normal or high | Disease; needs lifelong care |
| S/beta-zero thalassaemia | Absent | HbS mostly, HbA2 raised | Low | Disease as severe as SS; family study separates it from SS |
| HbSC disease | Absent | HbS and HbC about equal | Normal or low | Disease, often milder, with eye and bone complications |
| Beta-thalassaemia trait | Present | HbA2 above about 3.5% | Low | Carrier; iron deficiency can lower HbA2 and hide it |
| Alpha-thalassaemia trait | Present | HbA2 normal or low | Low | Normal analysis; confirm by DNA |
Reading errors
- HbE elutes in the HbA2 window on many HPLC systems, so an 'HbA2' far above 10% is usually HbE, not beta-thalassaemia trait.
- On alkaline electrophoresis HbS runs with HbD and HbG, and HbC with HbE and HbO; an acid gel or HPLC separates them.
- A transfused patient with sickle cell anaemia can look like sickle trait for up to about three months; always ask about transfusion.
- In Afro-Colombian communities of the Pacific and Caribbean coasts, HbS and HbC carriers are common; counselling partners before pregnancy prevents surprises.
- A solubility test shows HbS is present but cannot tell trait from disease; quantitation is always needed.
Next step
- Full count with MCV and MCH, ferritin, and a smear (target cells, sickle cells) with every analysis.
- Confirm any variant by a second method (HPLC plus electrophoresis or capillary electrophoresis).
- Low MCV with normal ferritin and normal HbA2: DNA testing for alpha-thalassaemia.
- Borderline HbA2 with iron deficiency: repeat after iron is replaced.
- Newborn screening results, compound states or prenatal questions: family studies and DNA testing, with genetic counselling.
Common traps
- Calling a transfused patient a sickle carrier: donor HbA can make sickle cell anaemia look like trait for months
- Excluding beta-thalassaemia trait with a normal HbA2 during iron deficiency: iron deficiency lowers HbA2, so repeat after iron
- Reading a huge 'HbA2' peak as thalassaemia trait: HbE elutes with HbA2 on HPLC
- Expecting the analysis to show alpha-thalassaemia trait: it is usually normal, so the diagnosis needs DNA
- Using a positive sickle solubility test to diagnose sickle cell disease: it is positive in trait and disease alike
Test yourself
Think of the answer, then tap the question to see it.
A woman from Buenaventura has HbA 58%, HbS 38%, normal MCV and no anaemia. What does this show, and what should she be offered?
Sickle trait: HbA exceeds HbS and the count is normal; she should be counselled and her partner offered testing before pregnancy.
A man with known sickle cell anaemia was transfused six weeks ago and now shows HbA 60% and HbS 35%. Why must this not be reported as sickle trait?
The HbA comes from donor red cells, which survive for months; the analysis reflects the transfusion, not his genes.
Why can a beta-thalassaemia carrier with heavy periods have a normal HbA2?
Iron deficiency lowers HbA2 synthesis and can bring a raised value into the normal range; repeating after iron replacement reveals the trait.
A microcytic adult has normal ferritin, normal HbA2 and no variant. Which test comes next?
DNA testing for alpha-thalassaemia, which usually gives a normal haemoglobin analysis in carriers.
Elsewhere in DurgiPedia
- Hemoglobin variants (HbA, HbA2, HbF, HbS, HbC)
- Sickle cell disease
- Thalassaemias: β and α
- Erythrocytes: shape, membrane skeleton, haemoglobin, lifespan
- Hemoglobin and 2,3-BPG
Connections
Educational content; it does not replace assessment by a doctor or your institution's protocols. It contains no doses.
Sources: Hemoglobin electrophoresis: MedlinePlus Medical Encyclopedia (MedlinePlus, US National Library of Medicine, 2026); Beta thalassemia: MedlinePlus Genetics (MedlinePlus, US National Library of Medicine, 2026); Alpha thalassemia: MedlinePlus Genetics (MedlinePlus, US National Library of Medicine, 2026); Sickle Cell Anemia (StatPearls Publishing (NCBI Bookshelf), 2023).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
